Law360, Washington (February 10, 2012, 5:36 PM ET) -- Three senators urged the White House Office of Management and Budget on Thursday to release a rule from the U.S. Food and Drug Administration on post-market medical device tracking that has been under review for over seven months.
In a letter directed to OMB Acting Director Jeffrey Zients, U.S. Sens. Herb Kohl, D-Wis.; Chuck Grassley, R-Iowa; and Richard Blumenthal, D-Conn., emphasized that the regulation could help the FDA bridge gaps in its medical device safety surveillance.
The FDA forwarded the so-called unique-device-identifier proposal to the OMB...
Sens. Press OMB For Delayed Medical Device Rule
To view the full article, take a free trial now.
